Literature DB >> 25629445

Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes.

Peter A Senior1, Melena D Bellin, Rodolfo Alejandro, Jon W Yankey, William R Clarke, Julie C Qidwai, Traci R Schwieger, Thomas L Eggerman, Mark A Robien, Michael R Rickels.   

Abstract

BACKGROUND: In long-standing type 1 diabetes (T1D), loss of endogenous insulin secretion and glucose dysregulation can lead to severe hypoglycemia and associated complications. Here, we report the serial consistency and the correlation between different scores that characterize glucose dysregulation using self-monitoring of blood glucose (SMBG), in a cohort of T1D individuals being evaluated for transplant eligibility in Clinical Islet Transplantation Consortium trials. SUBJECTS AND METHODS: In total, 152 C-peptide-negative T1D subjects with at least one severe hypoglycemia episode in the prior year documented SMBG at enrollment and every 6 months until deemed ineligible or transplanted. SMBG was used to calculate the HYPO score, Lability Index (LI), and mean amplitude of glycemic excursion (MAGE). Additionally, a blinded continuous glucose monitoring system (CGMS) was worn for 72 h at enrollment and every 12 months.
RESULTS: In this cohort, LI was the most consistent (intraclass correlation coefficient=0.70) over time, followed by the HYPO score (0.51), with MAGE being the least consistent (0.36). Although MAGE and LI were highly correlated with each other, neither correlated with CGMS SD or glucose coefficient of variation (CV). Subjects spent a median of 97 min/day at <54 mg/dL using CGMS. The HYPO score correlated with CGMS time below 54 mg/dL and glucose CV.
CONCLUSIONS: The HYPO score and LI are more consistent than MAGE in patients with established T1D experiencing severe hypoglycemic events and may be especially useful both for identifying subjects experiencing the greatest difficulty in maintaining glycemic control and for longitudinal assessment of novel interventions.

Entities:  

Mesh:

Year:  2015        PMID: 25629445      PMCID: PMC4447028          DOI: 10.1089/dia.2014.0289

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  22 in total

1.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.

Authors:  T Skrivarhaug; H-J Bangstad; L C Stene; L Sandvik; K F Hanssen; G Joner
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

Review 2.  Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.

Authors:  Philip E Cryer
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.

Authors:  Michael R Rickels; Mark H Schutta; Rebecca Mueller; Shiv Kapoor; James F Markmann; Ali Naji; Karen L Teff
Journal:  J Clin Endocrinol Metab       Date:  2006-12-27       Impact factor: 5.958

4.  Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring.

Authors:  P Choudhary; J Geddes; J V Freeman; C J Emery; S R Heller; B M Frier
Journal:  Diabet Med       Date:  2010-06       Impact factor: 4.359

5.  Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.

Authors:  Boris P Kovatchev; William L Clarke; Marc Breton; Kenneth Brayman; Anthony McCall
Journal:  Diabetes Technol Ther       Date:  2005-12       Impact factor: 6.118

6.  A novel approach to continuous glucose analysis utilizing glycemic variation.

Authors:  C M McDonnell; S M Donath; S I Vidmar; G A Werther; F J Cameron
Journal:  Diabetes Technol Ther       Date:  2005-04       Impact factor: 6.118

7.  Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.

Authors:  Ulrik Pedersen-Bjergaard; Stig Pramming; Simon R Heller; Tara M Wallace; Ase K Rasmussen; Hanne V Jørgensen; David R Matthews; Philip Hougaard; Birger Thorsteinsson
Journal:  Diabetes Metab Res Rev       Date:  2004 Nov-Dec       Impact factor: 4.876

8.  Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults.

Authors:  Richard G Feltbower; H Jonathan Bodansky; Christopher C Patterson; Roger C Parslow; Carolyn R Stephenson; Catherine Reynolds; Patricia A McKinney
Journal:  Diabetes Care       Date:  2008-02-19       Impact factor: 19.112

9.  Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.

Authors:  E S Kilpatrick; A S Rigby; K Goode; S L Atkin
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

10.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

View more
  14 in total

Review 1.  Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.

Authors:  Pratik Choudhary; Michael R Rickels; Peter A Senior; Marie-Christine Vantyghem; Paola Maffi; Thomas W Kay; Bart Keymeulen; Nobuya Inagaki; Frantisek Saudek; Roger Lehmann; Bernhard J Hering
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

2.  Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use.

Authors:  Andrew J Karter; E Margaret Warton; Kasia J Lipska; James D Ralston; Howard H Moffet; Geoffrey G Jackson; Elbert S Huang; Donald R Miller
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

Review 3.  Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.

Authors:  Michael R Rickels; Peter G Stock; Eelco J P de Koning; Lorenzo Piemonti; Johann Pratschke; Rodolfo Alejandro; Melena D Bellin; Thierry Berney; Pratik Choudhary; Paul R Johnson; Raja Kandaswamy; Thomas W H Kay; Bart Keymeulen; Yogish C Kudva; Esther Latres; Robert M Langer; Roger Lehmann; Barbara Ludwig; James F Markmann; Marjana Marinac; Jon S Odorico; François Pattou; Peter A Senior; James A M Shaw; Marie-Christine Vantyghem; Steven White
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

4.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Richard I G Holt; J Hans DeVries; Amy Hess-Fischl; Irl B Hirsch; M Sue Kirkman; Tomasz Klupa; Barbara Ludwig; Kirsten Nørgaard; Jeremy Pettus; Eric Renard; Jay S Skyler; Frank J Snoek; Ruth S Weinstock; Anne L Peters
Journal:  Diabetologia       Date:  2021-12       Impact factor: 10.122

5.  Evaluation of Clinical Metrics for Identifying Defective Physiologic Responses to Hypoglycemia in Long-Standing Type 1 Diabetes.

Authors:  Anneliese J Flatt; Elizabeth Chen; Amy J Peleckis; Cornelia Dalton-Bakes; Huong-Lan Nguyen; Heather W Collins; John S Millar; Robert J Gallop; Michael R Rickels
Journal:  Diabetes Technol Ther       Date:  2022-07-26       Impact factor: 7.337

6.  Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.

Authors:  Michael R Rickels; Amy J Peleckis; Eileen Markmann; Cornelia Dalton-Bakes; Stephanie M Kong; Karen L Teff; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2016-08-29       Impact factor: 5.958

Review 7.  Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.

Authors:  Michael R Rickels; Peter G Stock; Eelco J P de Koning; Lorenzo Piemonti; Johann Pratschke; Rodolfo Alejandro; Melena D Bellin; Thierry Berney; Pratik Choudhary; Paul R Johnson; Raja Kandaswamy; Thomas W H Kay; Bart Keymeulen; Yogish C Kudva; Esther Latres; Robert M Langer; Roger Lehmann; Barbara Ludwig; James F Markmann; Marjana Marinac; Jon S Odorico; François Pattou; Peter A Senior; James A M Shaw; Marie-Christine Vantyghem; Steven White
Journal:  Transpl Int       Date:  2018-04       Impact factor: 3.782

8.  Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes.

Authors:  Michael R Rickels; Amy J Peleckis; Cornelia Dalton-Bakes; Joseph R Naji; Nina A Ran; Huong-Lan Nguyen; Shannon O'Brien; Sanjian Chen; Insup Lee; Mark H Schutta
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 9.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

10.  Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.

Authors:  Cyril P Landstra; Axel Andres; Mikael Chetboun; Caterina Conte; Yvonne Kelly; Thierry Berney; Eelco J P de Koning; Lorenzo Piemonti; Peter G Stock; François Pattou; Marie-Christine Vantyghem; Melena D Bellin; Michael R Rickels
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.